A kidney transplant #patient with a rare, #multidrugresistant (MDR) infection has become the first to be treated using an adjunctive #bacteriophage therapy developed by Denmark's #SNIPRBiome.
pharmaphorum.com/news/snipr-p...
pharmaphorum.com/news/snipr-p...
SNIPR phage therapy clears MDR infection in first patient
A kidney transplant patient with a resistant infection is the first to be treated using a bacteriophage therapy developed by Denmark's SNIPR Biome.
pharmaphorum.com
August 12, 2026 at 9:30 AM
A kidney transplant #patient with a rare, #multidrugresistant (MDR) infection has become the first to be treated using an adjunctive #bacteriophage therapy developed by Denmark's #SNIPRBiome.
pharmaphorum.com/news/snipr-p...
pharmaphorum.com/news/snipr-p...
#cphftw #biotech company @sniprbiome grabs €35M Series B from the @CF_Foundation and @SPRIND, @lundbeckfonden BioCapital, North-East Family Office, and @wellingtonvc, to develop CRISPR therapies for infections and resistance. By @arcticstartup arcticstartup.com/snipr-biome-... #NordicMade
Danish biotech company grabs €35 million Series B to develop CRISPR therapies for infections and resistance - ArcticStartup
SNIPR BIOME, a clinical-stage biotech company based in Copenhagen, has raised €35 million in Series B funding to support the development of its CRISPR-based
arcticstartup.com
August 7, 2025 at 1:25 PM
#cphftw #biotech company @sniprbiome grabs €35M Series B from the @CF_Foundation and @SPRIND, @lundbeckfonden BioCapital, North-East Family Office, and @wellingtonvc, to develop CRISPR therapies for infections and resistance. By @arcticstartup arcticstartup.com/snipr-biome-... #NordicMade